Andropharm Issues Voluntary Nationwide Recall of Sten Z and M1 Alpha Due to Labeling that it Contains Derivatives of Anabolic Steroids
- Company Announcement Date:
- July 11, 2017
- FDA Publish Date:
- February 08, 2018
- Product Type:
- Dietary Supplements
- Reason for Announcement:
- Company Name:
- Brand Name:
- Product Description:
Product DescriptionSten Z and M1 Alphas capsules
Andropharm is voluntarily recalling all lots of Sten Z and M1 Alpha capsules to the consumer level because these products contain derivatives of anabolic steroids rendering them unapproved drugs for which safety and efficacy have not been established and therefore subject to recall.
Consumption of these products may cause elevated blood pressure, aggressive behavior, male infertility, or enlarged breasts and shrinkage of the testes in men. Patients with underlying cardiac, hepatic, or prostate conditions may be at higher risk for adverse reactions than otherwise healthy users. To date, Andropharm has not received any reports of these or any illnesses or injuries related to Sten Z or M1 Alpha.
Sten Z and M1 Alpha capsules are marketed as dietary supplements and promoted to increase, sustain, and strengthen muscularity. The two products were packaged as capsules in 60 count bottles with the UPC code-642125502948(Sten Z) and UPC code-642125502924(M1 Alpha) and were sold through retailers nationwide in the United States from March 2016 to April 2017. This recall applies to all lot numbers and expiration dates of these products.
Andropharm is notifying its retailer by a formal recall notification letter and arranging for a return of the recalled products. Consumers who have purchased Sten Z and M1 Alpha products should discontinue their use and either return them to their place of purchase or discard the products in accordance with state and local ordinances for disposal of the drug products.
Consumers with questions regarding this recall can contact Andropharm by phone at 1-855- 632-7667 or by email at Andropharmsales@gmail.com on Monday through Friday from 9am until 430pm Eastern Standard Time. Consumers should contact their physician or healthcare provider if they have experienced any problems that were related to taking either one of the recalled products.
Adverse reactions or quality problems experienced with the use of these products may also be reported to the FDA’s Medwatch Adverse Event Reporting program either online, by regular mail or by fax.
- Complete and submit the report Online: www.fda.gov/medwatch/report.htm
- Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.